I agree that this site is using cookies. You can find further informations here.
X
Siiskonen, Mira
14  results:
Search for persons X
?
1

Encouraging visual outcomes in children with idiopathic and..:

Siiskonen, Mira ; Hirn, Iida ; Pesälä, Roosa..
Pediatric Rheumatology.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
2

Effect of first-line antifungal treatment on ocular complic..:

Hautala, Nina ; Köykkä, Hannu ; Siiskonen, Mira...
BMJ Open Ophthalmology.  6 (2021)  1 - p. e000837 , 2021
Link: https://doi.org/10.1136/..
 
?
3

Prevalence, incidence and epidemiology of childhood uveitis:

Siiskonen, Mira ; Hirn, Iida ; Pesälä, Roosa...
Acta Ophthalmologica.  99 (2020)  2 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
4

Aetiology of posterior uveitis in a tertiary centre in Finl..:

Hautala, Nina ; Siiskonen, Mira ; Salmi, Juho.
Acta Ophthalmologica.  98 (2019)  1 - p. , 2019
Link: https://doi.org/10.1111/..
 
?
5

Early glycaemic control for maintaining visual function in ..:

Hautala, Nina ; Siiskonen, Mira ; Hannula, Virva..
European Journal of Ophthalmology.  28 (2018)  6 - p. 684-689 , 2018
Link: https://doi.org/10.1177/..
 
?
6

Encouraging visual outcomes in children with idiopathic and..:

Siiskonen, M. (Mira) ; Hirn, I. (Iida) ; Pesälä, R. (Roosa).. , 2023
Link: http://urn.fi/urn:nbn:fi..
 
?
7

Encouraging visual outcomes in children with idiopathic and..:

Mira Siiskonen ; Iida Hirn ; Roosa Pesälä..
https://doi.org/10.1186/s12969-023-00841-8.  , 2023
Link: https://doi.org/10.1186/..
 
?
8

Effect of first-line antifungal treatment on ocular complic..:

Nina Hautala ; Timo Hautala ; Juho Saari...
https://bmjophth.bmj.com/content/6/1/e000837.full.  , 2021
Link: https://doi.org/10.1136/..
 
?
9

Prevalence, incidence and epidemiology of childhood uveitis:

Siiskonen, M. (Mira) ; Hirn, I. (Iida) ; Pesälä, R. (Roosa)... , 2021
Link: http://urn.fi/urn:nbn:fi..
 
?
10

Effect of first-line antifungal treatment on ocular complic..:

Hautala, N. (Nina) ; Köykkä, H. (Hannu) ; Siiskonen, M. (Mira)... , 2021
Link: http://urn.fi/urn:nbn:fi..
 
?
11

COVID‐19 and the Emerging Regulatory Guidance for Ongoing C..:

de Jong, Amos Jochanan ; Santa‐Ana‐Tellez, Yared ; van Thiel, Ghislaine José Madeleine Wilhelmien...
Clinical Pharmacology & Therapeutics.  109 (2021)  6 - p. 1517-1527 , 2021
Link: https://doi.org/10.1002/..
 
?
12

Rapid Safety Assessment of SARS-CoV-2 Vaccines in EU Member..:

Durán, Carlos E ; Messina, Davide ; Gini, Rosa...
doi:10.5281/zenodo.8199481.  , 2023
Link: https://zenodo.org/recor..
 
?
13

Background rates of Adverse Events of Special Interest for ..:

Willame, C ; Dodd, C ; Gini, R...
doi:10.5281/zenodo.5255869.  , 2021
Link: https://zenodo.org/recor..
 
?
14

COVID-19 and the Emerging Regulatory Guidance for Ongoing C..:

Jong, Amos Jochanan de ; Santa-Ana-Tellez, Yared ; Thiel, Ghislaine José Madeleine Wilhelmien van...
0009-9236.  , 2021
Link: https://dspace.library.u..
 
1-14